Latest Post

January 06, 2020

The NovaPure® Component Portfolio – Solution for Lifecycle Management

It is essential to consider lifecycle management during the development of new drugs &ndash; especially in the evolving area of biologic drugs. The market demand for both ease of use, and patient-centric at-home administration, is driving the need for innovative container systems and delivery devices. Typically, drugs are launched in vials; continuous development often then enables launch in other formats, such as pre-filled syringes and cartridges. West is committed to easing this movement from container systems to delivery devices through its NovaPure<sup>&reg;</sup> component portfolio of elastomer closures. NovaPure stoppers and plungers offer best performance and highest quality. Developed with Quality-by-Design principles, they use FluroTec<sup>&reg;</sup> barrier film and B2 coating technologies.
Cathy Chhour

Cathy Chhour

Sr. Technical Account Specialist, TCS, NA

Previous Posts
By Your Side for Innovation

November 27, 2019

West Introduces NovaPure® 3mL Cartridge Components

Erin O'Brien

Erin O'Brien

VP, Product Management and Marketing Operations

SmartDose Gen II and Gen II

November 06, 2017

West Announces New Extensions of the SmartDose® Drug Delivery Platform

Deirdre Swinden

Deirdre Swinden

Director, Global Marketing Communications

Blue West logo with Diamond

September 09, 2015

Trends in Drug Delivery The Growth of Cartridge Based Technology

Royce Brockett

Royce Brockett

Sr. Manager, Marketing, PFS